Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1266 entries
Sorted by: Best Match Show Resources per page
The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial.

EClinicalMedicine

Rooney M, Bishop N, Davidson J, Beresford MW, Pilkington C, Donagh JM, Wyatt S, Gardner-Medwin J, Satyapal R, Clinch J, Foster H, Elliott M, Verghis R.
PMID: 31388666
EClinicalMedicine. 2019 Jul 03;12:79-87. doi: 10.1016/j.eclinm.2019.06.004. eCollection 2019 Jul.

BACKGROUND: Children and young people (CYP) with chronic rheumatic conditions; Juvenile Idiopathic Arthritis, Juvenile Systemic Lupus Erythematosus, Juvenile Dermatomyositis and Juvenile Vasculitis, treated with steroids, have low bone density, increased fracture risk and are likely to have suboptimal peak...

Cite
Rooney M, Bishop N, Davidson J, et al. The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial. EClinicalMedicine. 2019;12:79-87doi: 10.1016/j.eclinm.2019.06.004.
Rooney, M., Bishop, N., Davidson, J., Beresford, M. W., Pilkington, C., Donagh, J. M., Wyatt, S., Gardner-Medwin, J., Satyapal, R., Clinch, J., Foster, H., Elliott, M., Verghis, R. (2019). The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial. EClinicalMedicine, 1279-87. https://doi.org/10.1016/j.eclinm.2019.06.004
Rooney, Madeleine, et al. "The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial." EClinicalMedicine vol. 12 (2019): 79-87. doi: https://doi.org/10.1016/j.eclinm.2019.06.004
Rooney M, Bishop N, Davidson J, Beresford MW, Pilkington C, Donagh JM, Wyatt S, Gardner-Medwin J, Satyapal R, Clinch J, Foster H, Elliott M, Verghis R. The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial. EClinicalMedicine. 2019 Jul 03;12:79-87. doi: 10.1016/j.eclinm.2019.06.004. eCollection 2019 Jul. PMID: 31388666; PMCID: PMC6677647.
Copy Download .nbib Format: NLM
Commentary: Primary health care in Tanzania - Leading the way through innovation.

EClinicalMedicine

Bustreo F, Mshinda H, Hinton R, Hausmann-Muela S, Tanner M.
PMID: 31517258
EClinicalMedicine. 2019 Jul 27;13:12-13. doi: 10.1016/j.eclinm.2019.07.010. eCollection 2019 Aug.

No abstract available.

Cite
Bustreo F, Mshinda H, Hinton R, et al. Commentary: Primary health care in Tanzania - Leading the way through innovation. EClinicalMedicine. 2019;13:12-13doi: 10.1016/j.eclinm.2019.07.010.
Bustreo, F., Mshinda, H., Hinton, R., Hausmann-Muela, S., & Tanner, M. (2019). Commentary: Primary health care in Tanzania - Leading the way through innovation. EClinicalMedicine, 1312-13. https://doi.org/10.1016/j.eclinm.2019.07.010
Bustreo, Flavia, et al. "Commentary: Primary health care in Tanzania - Leading the way through innovation." EClinicalMedicine vol. 13 (2019): 12-13. doi: https://doi.org/10.1016/j.eclinm.2019.07.010
Bustreo F, Mshinda H, Hinton R, Hausmann-Muela S, Tanner M. Commentary: Primary health care in Tanzania - Leading the way through innovation. EClinicalMedicine. 2019 Jul 27;13:12-13. doi: 10.1016/j.eclinm.2019.07.010. eCollection 2019 Aug. PMID: 31517258; PMCID: PMC6734107.
Copy Download .nbib Format: NLM
Geographical Accessibility to District Hospitals/Medical Laboratories for Comprehensive Antenatal Point-of-Care Diagnostic Services in the Upper East Region, Ghana.

EClinicalMedicine

Kuupiel D, Adu KM, Bawontuo V, Mashamba-Thompson TP.
PMID: 31517264
EClinicalMedicine. 2019 Jul 03;13:74-80. doi: 10.1016/j.eclinm.2019.06.015. eCollection 2019 Aug.

BACKGROUND: Access to referral healthcare facilities from primary healthcare (PHC) clinics for diagnostic services is critical for improving maternal health outcomes. We described the geographical distribution and accessibility to district hospitals/medical laboratories for comprehensive antenatal point-of-care (POC) diagnostic services...

Cite
Kuupiel D, Adu KM, Bawontuo V, et al. Geographical Accessibility to District Hospitals/Medical Laboratories for Comprehensive Antenatal Point-of-Care Diagnostic Services in the Upper East Region, Ghana. EClinicalMedicine. 2019;13:74-80doi: 10.1016/j.eclinm.2019.06.015.
Kuupiel, D., Adu, K. M., Bawontuo, V., & Mashamba-Thompson, T. P. (2019). Geographical Accessibility to District Hospitals/Medical Laboratories for Comprehensive Antenatal Point-of-Care Diagnostic Services in the Upper East Region, Ghana. EClinicalMedicine, 1374-80. https://doi.org/10.1016/j.eclinm.2019.06.015
Kuupiel, Desmond, et al. "Geographical Accessibility to District Hospitals/Medical Laboratories for Comprehensive Antenatal Point-of-Care Diagnostic Services in the Upper East Region, Ghana." EClinicalMedicine vol. 13 (2019): 74-80. doi: https://doi.org/10.1016/j.eclinm.2019.06.015
Kuupiel D, Adu KM, Bawontuo V, Mashamba-Thompson TP. Geographical Accessibility to District Hospitals/Medical Laboratories for Comprehensive Antenatal Point-of-Care Diagnostic Services in the Upper East Region, Ghana. EClinicalMedicine. 2019 Jul 03;13:74-80. doi: 10.1016/j.eclinm.2019.06.015. eCollection 2019 Aug. PMID: 31517264; PMCID: PMC6734000.
Copy Download .nbib Format: NLM
Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study.

EClinicalMedicine

Hatleberg CI, Ryom L, Kamara D, De Wit S, Law M, Phillips A, Reiss P, D'Arminio Monforte A, Mocroft A, Pradier C, Kirk O, Kovari H, Bonnet F, El-Sadr W, Lundgren JD, Sabin C.
PMID: 31517266
EClinicalMedicine. 2019 Aug 11;13:91-100. doi: 10.1016/j.eclinm.2019.07.008. eCollection 2019 Aug.

BACKGROUND: Hypertension is a stronger predictor of hemorrhagic than ischemic strokes in the general population. We aimed to identify whether hypertension or other risk factors, including HIV-related factors, differ in their associations with stroke subtypes in people living with...

Cite
Hatleberg CI, Ryom L, Kamara D, et al. Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study. EClinicalMedicine. 2019;13:91-100doi: 10.1016/j.eclinm.2019.07.008.
Hatleberg, C. I., Ryom, L., Kamara, D., De Wit, S., Law, M., Phillips, A., Reiss, P., D'Arminio Monforte, A., Mocroft, A., Pradier, C., Kirk, O., Kovari, H., Bonnet, F., El-Sadr, W., Lundgren, J. D., Sabin, C. (2019). Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study. EClinicalMedicine, 1391-100. https://doi.org/10.1016/j.eclinm.2019.07.008
Hatleberg, Camilla Ingrid, et al. "Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study." EClinicalMedicine vol. 13 (2019): 91-100. doi: https://doi.org/10.1016/j.eclinm.2019.07.008
Hatleberg CI, Ryom L, Kamara D, De Wit S, Law M, Phillips A, Reiss P, D'Arminio Monforte A, Mocroft A, Pradier C, Kirk O, Kovari H, Bonnet F, El-Sadr W, Lundgren JD, Sabin C. Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study. EClinicalMedicine. 2019 Aug 11;13:91-100. doi: 10.1016/j.eclinm.2019.07.008. eCollection 2019 Aug. PMID: 31517266; PMCID: PMC6737207.
Copy Download .nbib Format: NLM
Finding a way in the information age.

EClinicalMedicine

[No authors listed]
PMID: 31388654
EClinicalMedicine. 2019 Jul 30;12:1. doi: 10.1016/j.eclinm.2019.07.011. eCollection 2019 Jul.

No abstract available.

Cite
Finding a way in the information age. EClinicalMedicine. 2019;12:1doi: 10.1016/j.eclinm.2019.07.011.
(2019). Finding a way in the information age. EClinicalMedicine, 121. https://doi.org/10.1016/j.eclinm.2019.07.011
"Finding a way in the information age." EClinicalMedicine vol. 12 (2019): 1. doi: https://doi.org/10.1016/j.eclinm.2019.07.011
Finding a way in the information age. EClinicalMedicine. 2019 Jul 30;12:1. doi: 10.1016/j.eclinm.2019.07.011. eCollection 2019 Jul. PMID: 31388654; PMCID: PMC6677651.
Copy Download .nbib Format: NLM
Use of Routine Health Information System Data to Evaluate Impact of Malaria Control Interventions in Zanzibar, Tanzania from 2000 to 2015.

EClinicalMedicine

Ashton RA, Bennett A, Al-Mafazy AW, Abass AK, Msellem MI, McElroy P, Kachur SP, Ali AS, Yukich J, Eisele TP, Bhattarai A.
PMID: 31388659
EClinicalMedicine. 2019 Jun 21;12:11-19. doi: 10.1016/j.eclinm.2019.05.011. eCollection 2019 Jul.

BACKGROUND: Impact evaluations allow countries to assess public health gains achieved through malaria investments. This study uses routine health management information system (HMIS) data from Zanzibar to describe changes in confirmed malaria incidence and impact of case management and...

Cite
Ashton RA, Bennett A, Al-Mafazy AW, et al. Use of Routine Health Information System Data to Evaluate Impact of Malaria Control Interventions in Zanzibar, Tanzania from 2000 to 2015. EClinicalMedicine. 2019;12:11-19doi: 10.1016/j.eclinm.2019.05.011.
Ashton, R. A., Bennett, A., Al-Mafazy, A. W., Abass, A. K., Msellem, M. I., McElroy, P., Kachur, S. P., Ali, A. S., Yukich, J., Eisele, T. P., & Bhattarai, A. (2019). Use of Routine Health Information System Data to Evaluate Impact of Malaria Control Interventions in Zanzibar, Tanzania from 2000 to 2015. EClinicalMedicine, 1211-19. https://doi.org/10.1016/j.eclinm.2019.05.011
Ashton, Ruth A, et al. "Use of Routine Health Information System Data to Evaluate Impact of Malaria Control Interventions in Zanzibar, Tanzania from 2000 to 2015." EClinicalMedicine vol. 12 (2019): 11-19. doi: https://doi.org/10.1016/j.eclinm.2019.05.011
Ashton RA, Bennett A, Al-Mafazy AW, Abass AK, Msellem MI, McElroy P, Kachur SP, Ali AS, Yukich J, Eisele TP, Bhattarai A. Use of Routine Health Information System Data to Evaluate Impact of Malaria Control Interventions in Zanzibar, Tanzania from 2000 to 2015. EClinicalMedicine. 2019 Jun 21;12:11-19. doi: 10.1016/j.eclinm.2019.05.011. eCollection 2019 Jul. PMID: 31388659; PMCID: PMC6677660.
Copy Download .nbib Format: NLM
High-flow Nasal Cannulae Versus Non-invasive Ventilation for Preoxygenation of Obese Patients: The PREOPTIPOP Randomized Trial.

EClinicalMedicine

Vourc'h M, Baud G, Feuillet F, Blanchard C, Mirallie E, Guitton C, Jaber S, Asehnoune K.
PMID: 31528849
EClinicalMedicine. 2019 Jun 05;13:112-119. doi: 10.1016/j.eclinm.2019.05.014. eCollection 2019 Aug.

No abstract available.

Cite
Vourc'h M, Baud G, Feuillet F, et al. High-flow Nasal Cannulae Versus Non-invasive Ventilation for Preoxygenation of Obese Patients: The PREOPTIPOP Randomized Trial. EClinicalMedicine. 2019;13:112-119doi: 10.1016/j.eclinm.2019.05.014.
Vourc'h, M., Baud, G., Feuillet, F., Blanchard, C., Mirallie, E., Guitton, C., Jaber, S., & Asehnoune, K. (2019). High-flow Nasal Cannulae Versus Non-invasive Ventilation for Preoxygenation of Obese Patients: The PREOPTIPOP Randomized Trial. EClinicalMedicine, 13112-119. https://doi.org/10.1016/j.eclinm.2019.05.014
Vourc'h, Mickael, et al. "High-flow Nasal Cannulae Versus Non-invasive Ventilation for Preoxygenation of Obese Patients: The PREOPTIPOP Randomized Trial." EClinicalMedicine vol. 13 (2019): 112-119. doi: https://doi.org/10.1016/j.eclinm.2019.05.014
Vourc'h M, Baud G, Feuillet F, Blanchard C, Mirallie E, Guitton C, Jaber S, Asehnoune K. High-flow Nasal Cannulae Versus Non-invasive Ventilation for Preoxygenation of Obese Patients: The PREOPTIPOP Randomized Trial. EClinicalMedicine. 2019 Jun 05;13:112-119. doi: 10.1016/j.eclinm.2019.05.014. eCollection 2019 Aug. PMID: 31528849; PMCID: PMC6737343.
Copy Download .nbib Format: NLM
Higher volume providers are associated with improved outcomes following ERCP for the palliation of malignant biliary obstruction.

EClinicalMedicine

Harvey PR, Baldwin S, Mytton J, Dosanjh A, Evison F, Patel P, Trudgill NJ.
PMID: 31922117
EClinicalMedicine. 2020 Jan 03;18:100212. doi: 10.1016/j.eclinm.2019.11.005. eCollection 2020 Jan.

BACKGROUND: Relieving malignant biliary obstruction improves quality of life and permits chemotherapy. Outcomes of endoscopic retrograde cholangio-pancratography(ERCP) in inoperable malignant biliary obstruction have been examined in a national cohort to establish factors associated with poor outcomes.METHODS: Hospital Episode Statistics...

Cite
Harvey PR, Baldwin S, Mytton J, et al. Higher volume providers are associated with improved outcomes following ERCP for the palliation of malignant biliary obstruction. EClinicalMedicine. 2020;18:100212doi: 10.1016/j.eclinm.2019.11.005.
Harvey, P. R., Baldwin, S., Mytton, J., Dosanjh, A., Evison, F., Patel, P., & Trudgill, N. J. (2020). Higher volume providers are associated with improved outcomes following ERCP for the palliation of malignant biliary obstruction. EClinicalMedicine, 18100212. https://doi.org/10.1016/j.eclinm.2019.11.005
Harvey, Philip R, et al. "Higher volume providers are associated with improved outcomes following ERCP for the palliation of malignant biliary obstruction." EClinicalMedicine vol. 18 (2020): 100212. doi: https://doi.org/10.1016/j.eclinm.2019.11.005
Harvey PR, Baldwin S, Mytton J, Dosanjh A, Evison F, Patel P, Trudgill NJ. Higher volume providers are associated with improved outcomes following ERCP for the palliation of malignant biliary obstruction. EClinicalMedicine. 2020 Jan 03;18:100212. doi: 10.1016/j.eclinm.2019.11.005. eCollection 2020 Jan. PMID: 31922117; PMCID: PMC6948226.
Copy Download .nbib Format: NLM
Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa.

EClinicalMedicine

Villa G, Abdullahi A, Owusu D, Smith C, Azumah M, Sayeed L, Austin H, Awuah D, Beloukas A, Chadwick D, Phillips R, Geretti AM.
PMID: 31922120
EClinicalMedicine. 2020 Jan 05;18:100231. doi: 10.1016/j.eclinm.2019.12.001. eCollection 2020 Jan.

BACKGROUND: This prospective pilot study explored same-day point-of-care viral load testing in a setting in Ghana that has yet to implement virological monitoring of antiretroviral therapy (ART).METHODS: Consecutive patients accessing outpatient care while on ART underwent HIV-1 RNA quantification...

Cite
Villa G, Abdullahi A, Owusu D, et al. Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa. EClinicalMedicine. 2020;18:100231doi: 10.1016/j.eclinm.2019.12.001.
Villa, G., Abdullahi, A., Owusu, D., Smith, C., Azumah, M., Sayeed, L., Austin, H., Awuah, D., Beloukas, A., Chadwick, D., Phillips, R., & Geretti, A. M. (2020). Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa. EClinicalMedicine, 18100231. https://doi.org/10.1016/j.eclinm.2019.12.001
Villa, Giovanni, et al. "Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa." EClinicalMedicine vol. 18 (2020): 100231. doi: https://doi.org/10.1016/j.eclinm.2019.12.001
Villa G, Abdullahi A, Owusu D, Smith C, Azumah M, Sayeed L, Austin H, Awuah D, Beloukas A, Chadwick D, Phillips R, Geretti AM. Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa. EClinicalMedicine. 2020 Jan 05;18:100231. doi: 10.1016/j.eclinm.2019.12.001. eCollection 2020 Jan. PMID: 31922120; PMCID: PMC6948257.
Copy Download .nbib Format: NLM
Impact of age on optimal dose of antidepressants.

EClinicalMedicine

Hashimoto K.
PMID: 31922121
EClinicalMedicine. 2020 Jan 03;18:100233. doi: 10.1016/j.eclinm.2019.12.003. eCollection 2020 Jan.

No abstract available.

Cite
Hashimoto K. Impact of age on optimal dose of antidepressants. EClinicalMedicine. 2020;18:100233doi: 10.1016/j.eclinm.2019.12.003.
Hashimoto, K. (2020). Impact of age on optimal dose of antidepressants. EClinicalMedicine, 18100233. https://doi.org/10.1016/j.eclinm.2019.12.003
Hashimoto, Kenji. "Impact of age on optimal dose of antidepressants." EClinicalMedicine vol. 18 (2020): 100233. doi: https://doi.org/10.1016/j.eclinm.2019.12.003
Hashimoto K. Impact of age on optimal dose of antidepressants. EClinicalMedicine. 2020 Jan 03;18:100233. doi: 10.1016/j.eclinm.2019.12.003. eCollection 2020 Jan. PMID: 31922121; PMCID: PMC6948222.
Copy Download .nbib Format: NLM
Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001-2017).

EClinicalMedicine

Zuo L, Liu K, Liu H, Hu Y, Zhang Z, Qin J, Xu Q, Peng K, Jin X, Wang JH, Zhang C.
PMID: 31922125
EClinicalMedicine. 2020 Jan 05;18:100238. doi: 10.1016/j.eclinm.2019.100238. eCollection 2020 Jan.

BACKGROUND: The emergence and spread of HIV-1 drug resistance may compromise HIV control globally. In response to HIV/AIDS epidemic, China launched national HIV/AIDS treatment program in 2003, and started to accumulate drug resistance data since 2001. In this study...

Cite
Zuo L, Liu K, Liu H, et al. Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001-2017). EClinicalMedicine. 2020;18:100238doi: 10.1016/j.eclinm.2019.100238.
Zuo, L., Liu, K., Liu, H., Hu, Y., Zhang, Z., Qin, J., Xu, Q., Peng, K., Jin, X., Wang, J. H., & Zhang, C. (2020). Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001-2017). EClinicalMedicine, 18100238. https://doi.org/10.1016/j.eclinm.2019.100238
Zuo, Lulu, et al. "Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001-2017)." EClinicalMedicine vol. 18 (2020): 100238. doi: https://doi.org/10.1016/j.eclinm.2019.100238
Zuo L, Liu K, Liu H, Hu Y, Zhang Z, Qin J, Xu Q, Peng K, Jin X, Wang JH, Zhang C. Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001-2017). EClinicalMedicine. 2020 Jan 05;18:100238. doi: 10.1016/j.eclinm.2019.100238. eCollection 2020 Jan. PMID: 31922125; PMCID: PMC6948268.
Copy Download .nbib Format: NLM
HIV drug resistance and antiretroviral therapy programs in Henan, China.

EClinicalMedicine

Liu ZB, Li Q, Guo H.
PMID: 32099967
EClinicalMedicine. 2020 Feb 17;19:100275. doi: 10.1016/j.eclinm.2020.100275. eCollection 2020 Feb.

No abstract available.

Cite
Liu ZB, Li Q, Guo H. HIV drug resistance and antiretroviral therapy programs in Henan, China. EClinicalMedicine. 2020;19:100275doi: 10.1016/j.eclinm.2020.100275.
Liu, Z. B., Li, Q., & Guo, H. (2020). HIV drug resistance and antiretroviral therapy programs in Henan, China. EClinicalMedicine, 19100275. https://doi.org/10.1016/j.eclinm.2020.100275
Liu, Zhi-Bin, et al. "HIV drug resistance and antiretroviral therapy programs in Henan, China." EClinicalMedicine vol. 19 (2020): 100275. doi: https://doi.org/10.1016/j.eclinm.2020.100275
Liu ZB, Li Q, Guo H. HIV drug resistance and antiretroviral therapy programs in Henan, China. EClinicalMedicine. 2020 Feb 17;19:100275. doi: 10.1016/j.eclinm.2020.100275. eCollection 2020 Feb. PMID: 32099967; PMCID: PMC7029157.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1266 entries